Header Logo

Connection

SUSAN ABUGHOSH to Middle Aged

Back to Details
This is a "connection" page, showing publications SUSAN ABUGHOSH has written about Middle Aged.
SUSAN ABUGHOSH
Connection Strength
0.892
Middle Aged
  1. Evaluating time to treatment intensification among drug na?ve type 2 diabetes patients: a comparison of initial combination therapy vs step-therapy approaches. Curr Med Res Opin. 2026 Apr; 42(4):699-711.
    View in: PubMed
    Score: 0.058
  2. Effect of the initial combination approach vs initial monotherapy approach on 1-year trajectories of adherence in drug-naive patients with type 2 diabetes. J Manag Care Spec Pharm. 2026 Jun; 32(6):717-734.
    View in: PubMed
    Score: 0.058
  3. Effect of initial combination therapy vs. step-therapy on adherence and persistence in drug na?ve type 2 diabetes patients. J Diabetes Complications. 2025 09; 39(9):109080.
    View in: PubMed
    Score: 0.054
  4. Treatment refractoriness and response rates in patients with relapsed/refractory multiple myeloma: a retrospective analysis of real-world data. Cancer Treat Res Commun. 2025; 43:100921.
    View in: PubMed
    Score: 0.053
  5. Real-world treatment patterns in drug na?ve type 2 diabetes population: Initial combination therapy vs. sequential step-therapy. J Am Pharm Assoc (2003). 2025 Jan-Feb; 65(1):102295.
    View in: PubMed
    Score: 0.052
  6. Evaluating perceptions of social determinants of health and Part D star performance of Medicare Advantage-contracted primary care providers serving a South Texas market. J Manag Care Spec Pharm. 2021 May; 27(5):544-553.
    View in: PubMed
    Score: 0.041
  7. Identifying adherent patients to newly initiated statins using previous adherence to chronic medications. J Manag Care Spec Pharm. 2021 Feb; 27(2):186-197.
    View in: PubMed
    Score: 0.040
  8. Risk of Cardiovascular Outcomes and Antihypertensive Triple Combination Therapy Among Elderly Patients with Hypertension Enrolled in a Medicare Advantage Plan (MAP). Am J Cardiovasc Drugs. 2020 Dec; 20(6):591-602.
    View in: PubMed
    Score: 0.040
  9. A retrospective study of drug utilization and hospital readmissions among Medicare patients with hepatic encephalopathy. Medicine (Baltimore). 2020 Apr; 99(16):e19603.
    View in: PubMed
    Score: 0.038
  10. Enhancing Statin Adherence Using a Motivational Interviewing Intervention and Past Adherence Trajectories in Patients with Suboptimal Adherence. J Manag Care Spec Pharm. 2019 Oct; 25(10):1053-1062.
    View in: PubMed
    Score: 0.036
  11. Medication Adherence to Antihypertensive Triple-Combination Therapy Among Patients Enrolled in a Medicare Advantage Plan. J Manag Care Spec Pharm. 2019 Jun; 25(6):678-686.
    View in: PubMed
    Score: 0.036
  12. Identifying adherence barriers to oral endocrine therapy among breast cancer survivors. Breast Cancer Res Treat. 2019 Apr; 174(2):297-305.
    View in: PubMed
    Score: 0.034
  13. A Motivational Interviewing Intervention by Pharmacy Students to Improve Medication Adherence. J Manag Care Spec Pharm. 2017 May; 23(5):549-560.
    View in: PubMed
    Score: 0.031
  14. Comparative Effectiveness of Smoking Cessation Medications to Attenuate Weight Gain Following Cessation. Subst Use Misuse. 2016; 51(5):586-97.
    View in: PubMed
    Score: 0.029
  15. Comparison of Diabetes Risk Following Smoking Cessation Treatment Using Varenicline Versus Bupropion Among Obese Smokers. Subst Use Misuse. 2015; 50(13):1628-37.
    View in: PubMed
    Score: 0.028
  16. The relationship between obesity and prescription of smoking cessation medications. Popul Health Manag. 2014 Jun; 17(3):172-9.
    View in: PubMed
    Score: 0.025
  17. Predictors of smoking cessation medication use among nonobese and obese smokers. Subst Use Misuse. 2014 May; 49(6):752-61.
    View in: PubMed
    Score: 0.025
  18. Differences in obesity management among physicians. Popul Health Manag. 2012 Oct; 15(5):287-92.
    View in: PubMed
    Score: 0.022
  19. Interventions to improve adherence to oral endocrine therapy for prevention or treatment of breast cancer in Black women of low socioeconomic status. Support Care Cancer. 2025 Dec 11; 34(1):24.
    View in: PubMed
    Score: 0.014
  20. Decreased persistence to cholinesterase inhibitor therapy with concomitant use of drugs that can impair cognition. Pharmacotherapy. 2005 Dec; 25(12):1729-35.
    View in: PubMed
    Score: 0.014
  21. Identification of factors associated with non-adherence to oral endocrine therapy in breast cancer patients of low socioeconomic status: a single centre retrospective study. Int J Clin Pharm. 2026 Feb; 48(1):266-273.
    View in: PubMed
    Score: 0.014
  22. Non-adherence of cyclin-dependent kinases 4 and 6 inhibitors reduces overall and progression-free survival in patients with hormone receptor-positive breast cancer. Breast Cancer Res Treat. 2025 Jul; 212(1):71-78.
    View in: PubMed
    Score: 0.013
  23. Concurrent Depression Management in Patients with Opioid Use Disorder Undergoing Buprenorphine Therapy: Association with Buprenorphine Discontinuation. J Dual Diagn. 2025 Apr; 21(2):142-151.
    View in: PubMed
    Score: 0.013
  24. Racial and Ethnic Disparities in Access to Care Among Adults with Cardiovascular Disease. J Health Care Poor Underserved. 2025; 36(1):96-114.
    View in: PubMed
    Score: 0.013
  25. Racial and Ethnic Disparities in Perceived Health Status Among Patients With Cardiovascular Disease. Prev Chronic Dis. 2024 11 14; 21:E89.
    View in: PubMed
    Score: 0.013
  26. Racial and Ethnic Disparity in Healthcare Expenditure and Resource Utilization Among Patients with Cardiovascular Diseases. J Racial Ethn Health Disparities. 2025 10; 12(5):3210-3222.
    View in: PubMed
    Score: 0.013
  27. Immunomodulator adherence in multiple myeloma patients with lower socioeconomic status: a retrospective study. Support Care Cancer. 2024 Jun 04; 32(7):407.
    View in: PubMed
    Score: 0.013
  28. Development and internal validation of a risk prediction model for HIV disease severity among people living with HIV and mental illness or substance use disorder. Ann Epidemiol. 2023 11; 87:79-92.
    View in: PubMed
    Score: 0.012
  29. Oral Endocrine Therapy Agent, Race/Ethnicity, and Time on Therapy Predict Adherence in Breast Cancer Patients in a Large Academic Institution. Clin Breast Cancer. 2020 12; 20(6):520-526.
    View in: PubMed
    Score: 0.010
  30. Drug Enforcement Administration Rescheduling of Hydrocodone Combination Products Is Associated With Changes in Physician Pain Management Prescribing Preferences. J Pain Palliat Care Pharmacother. 2019 Mar - Jun; 33(1-2):22-31.
    View in: PubMed
    Score: 0.009
  31. Neratinib in HER2-Positive Breast Cancer Patients. Ann Pharmacother. 2019 06; 53(6):612-620.
    View in: PubMed
    Score: 0.009
  32. Physicians' intention to prescribe hydrocodone combination products after rescheduling: A theory of reasoned action approach. Res Social Adm Pharm. 2017 May - Jun; 13(3):503-512.
    View in: PubMed
    Score: 0.007
  33. Smoking Cessation Support Among Oncology Practitioners in a Regional Cancer Center in the Middle East-Improving a Critical Service for Cancer Care. Oncologist. 2016 Apr; 21(4):503-5.
    View in: PubMed
    Score: 0.007
  34. Evaluating Pharmacist-Written Recommendations to Providers in a Medicare Advantage Plan: Factors Associated with Provider Acceptance. J Manag Care Spec Pharm. 2016 Jan; 22(1):49-55.
    View in: PubMed
    Score: 0.007
  35. The Role of Socioeconomic Status and Health Care Access in Breast Cancer Screening Compliance Among Hispanics. J Public Health Manag Pract. 2015 Sep-Oct; 21(5):467-76.
    View in: PubMed
    Score: 0.007
  36. Risk factors for vitamin D deficiency in HIV-infected patients in the south central United States. AIDS Res Hum Retroviruses. 2012 May; 28(5):454-9.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.